156 related articles for article (PubMed ID: 33791838)
1. Feasibility and safety of quantitative adenosine stress perfusion cardiac magnetic resonance imaging in pediatric heart transplant patients with and without coronary allograft vasculopathy.
Duran SR; Huffaker T; Dixon B; Gooty V; Abou Zahr R; Arar Y; Greer JS; Butts RJ; Hussain MT
Pediatr Radiol; 2021 Jul; 51(8):1311-1321. PubMed ID: 33791838
[TBL] [Abstract][Full Text] [Related]
2. Multi-parametric cardiovascular magnetic resonance with regadenoson stress perfusion is safe following pediatric heart transplantation and identifies history of rejection and cardiac allograft vasculopathy.
Husain N; Watanabe K; Berhane H; Gupta A; Markl M; Rigsby CK; Robinson JD
J Cardiovasc Magn Reson; 2021 Nov; 23(1):135. PubMed ID: 34809650
[TBL] [Abstract][Full Text] [Related]
3. Magnetic Resonance for Noninvasive Detection of Microcirculatory Disease Associated With Allograft Vasculopathy: Intracoronary Measurement Validation.
Mirelis JG; García-Pavía P; Cavero MA; González-López E; Echavarria-Pinto M; Pastrana M; Segovia J; Oteo JF; Alonso-Pulpón L; Escaned J
Rev Esp Cardiol (Engl Ed); 2015 Jul; 68(7):571-8. PubMed ID: 25522835
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of Real-Time Myocardial Contrast Echocardiography to Detect Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
Fine NM; Greenway SC; Mulvagh SL; Huang R; Maxon SA; Hepinstall MJ; Anderson JH; Johnson JN
J Am Soc Echocardiogr; 2021 May; 34(5):503-510. PubMed ID: 33359634
[TBL] [Abstract][Full Text] [Related]
5. Myocardial Perfusion Reserve and Strain-Encoded CMR for Evaluation of Cardiac Allograft Microvasculopathy.
Erbel C; Mukhammadaminova N; Gleissner CA; Osman NF; Hofmann NP; Steuer C; Akhavanpoor M; Wangler S; Celik S; Doesch AO; Voss A; Buss SJ; Schnabel PA; Katus HA; Korosoglou G
JACC Cardiovasc Imaging; 2016 Mar; 9(3):255-66. PubMed ID: 26965729
[TBL] [Abstract][Full Text] [Related]
6. Cardiac magnetic resonance imaging myocardial perfusion reserve index in heart transplant patients.
Jiménez-Jaso JM; Ezponda A; Sáenz-Diez JM; Caballeros M; Rábago G; Bastarrika G
Radiologia (Engl Ed); 2020; 62(6):493-501. PubMed ID: 32493651
[TBL] [Abstract][Full Text] [Related]
7. Semi-quantitative myocardial perfusion MRI in heart transplant recipients at rest: repeatability in healthy controls and assessment of cardiac allograft vasculopathy.
DeSa TB; Abbasi MA; Blaisdell JA; Lin K; Collins JD; Carr JC; Markl M
Clin Imaging; 2020 May; 61():62-68. PubMed ID: 31981959
[TBL] [Abstract][Full Text] [Related]
8. Myocardial perfusion reserve and global longitudinal strain as potential markers of coronary allograft vasculopathy in late-stage orthotopic heart transplantation.
Narang A; Blair JE; Patel MB; Mor-Avi V; Fedson SE; Uriel N; Lang RM; Patel AR
Int J Cardiovasc Imaging; 2018 Oct; 34(10):1607-1617. PubMed ID: 29728952
[TBL] [Abstract][Full Text] [Related]
9. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy.
Miller CA; Sarma J; Naish JH; Yonan N; Williams SG; Shaw SM; Clark D; Pearce K; Stout M; Potluri R; Borg A; Coutts G; Chowdhary S; McCann GP; Parker GJ; Ray SG; Schmitt M
J Am Coll Cardiol; 2014 Mar; 63(8):799-808. PubMed ID: 24355800
[TBL] [Abstract][Full Text] [Related]
11. Identification of coronary artery disease in the pediatric cardiac transplant patient.
Maiers J; Hurwitz R
Pediatr Cardiol; 2008 Jan; 29(1):19-23. PubMed ID: 17891435
[TBL] [Abstract][Full Text] [Related]
12. Outcomes after percutaneous coronary artery revascularization procedures for cardiac allograft vasculopathy in pediatric heart transplant recipients: A multi-institutional study.
Jeewa A; Chin C; Pahl E; Atz AM; Carboni MP; Pruitt E; Naftel DC; Rodriguez R; Dipchand AI;
J Heart Lung Transplant; 2015 Sep; 34(9):1163-8. PubMed ID: 25578627
[TBL] [Abstract][Full Text] [Related]
13. Myocardial stress perfusion magnetic resonance: initial experience in a pediatric and young adult population using regadenoson.
Noel CV; Krishnamurthy R; Moffett B; Krishnamurthy R
Pediatr Radiol; 2017 Mar; 47(3):280-289. PubMed ID: 28035425
[TBL] [Abstract][Full Text] [Related]
14. Coronary flow reserve measurement detects transplant coronary artery disease in pediatric heart transplant patients.
Schubert S; Abdul-Khaliq H; Wellnhofer E; Hiemann NE; Ewert P; Lehmkuhl HB; Meyer R; Miera O; Peters B; Hetzer R; Berger F
J Heart Lung Transplant; 2008 May; 27(5):514-21. PubMed ID: 18442717
[TBL] [Abstract][Full Text] [Related]
15. Dual-Axis Rotational Angiography is Safe and Feasible to Detect Coronary Allograft Vasculopathy in Pediatric Heart Transplant Patients: A Single-Center Experience.
Rios R; Loomba RS; Foerster SR; Pelech AN; Gudausky TM
Pediatr Cardiol; 2016 Apr; 37(4):740-5. PubMed ID: 26846123
[TBL] [Abstract][Full Text] [Related]
16. Reduced Myocardial Flow Reserve by Positron Emission Tomography Predicts Cardiovascular Events After Cardiac Transplantation.
Konerman MC; Lazarus JJ; Weinberg RL; Shah RV; Ghannam M; Hummel SL; Corbett JR; Ficaro EP; Aaronson KD; Colvin MM; Koelling TM; Murthy VL
Circ Heart Fail; 2018 Jun; 11(6):e004473. PubMed ID: 29891737
[TBL] [Abstract][Full Text] [Related]
17. The challenge to detect heart transplant rejection and transplant vasculopathy non-invasively - a pilot study.
Usta E; Burgstahler C; Aebert H; Schroeder S; Helber U; Kopp AF; Ziemer G
J Cardiothorac Surg; 2009 Aug; 4():43. PubMed ID: 19682394
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive morphologic and functional imaging of heart transplant patients: first experience with dynamic perfusion CT.
Oebel S; Hamada S; Higashigaito K; von Spiczak J; Klotz E; Enseleit F; Hinzpeter R; Ruschitzka F; Manka R; Alkadhi H
Eur Radiol; 2018 Oct; 28(10):4111-4121. PubMed ID: 29713770
[TBL] [Abstract][Full Text] [Related]
19. PET Myocardial Blood Flow for Post-transplant Surveillance and Cardiac Allograft Vasculopathy in Heart Transplant Recipients.
Feher A; Miller EJ
Curr Cardiol Rep; 2022 Dec; 24(12):1865-1871. PubMed ID: 36279035
[TBL] [Abstract][Full Text] [Related]
20. Safety and prognostic value of regadenoson stress cardiovascular magnetic resonance imaging in heart transplant recipients.
Kazmirczak F; Nijjar PS; Zhang L; Hughes A; Chen KA; Okasha O; Martin CM; Akçakaya M; Farzaneh-Far A; Shenoy C
J Cardiovasc Magn Reson; 2019 Jan; 21(1):9. PubMed ID: 30674318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
